Company news
NexGel, Inc news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-Year
May 12, 2024
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
May 8, 2024
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
March 31, 2024
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8: 30 a.m. ET Due to Holiday
March 26, 2024
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
March 20, 2024
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
February 20, 2024
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
January 8, 2024
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
December 10, 2023
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line
December 4, 2023
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
November 12, 2023
NEXGEL to Report Third Quarter 2023 Financial Results on November 13th
November 1, 2023
NEXGEL Secures Supply Agreement with AbbVie
October 29, 2023
NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-Year
August 13, 2023
NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America
July 18, 2023
NEXGEL Reports First Quarter 2023 Financial Results
May 14, 2023
NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results
March 26, 2023
NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th
March 14, 2023
NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business
March 1, 2023
NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee
January 16, 2023
NEXGEL Announces Share Repurchase Program
December 6, 2022
NEXGEL Reports Third Quarter 2022 Financial Results
November 7, 2022
NEXGEL to Report Third Quarter 2022 Financial Results on November 8th
November 1, 2022
NEXGEL Appoints Dr. Leonard Nelson and Dr. Neil Chesen to Scientific Advisory Board
September 28, 2022
NEXGEL Reports Second Quarter 2022 Financial Results
August 9, 2022
NEXGEL Reports First Quarter 2022 Financial Results
May 11, 2022
NEXGEL to Report its First Quarter 2022 Financial and Operating Results on May 12, 2022
May 8, 2022
NEXGEL Reports Fourth Quarter and Full Year 2021 Financial Results
March 20, 2022
NEXGEL Announces Launch of MEDAGEL Bug Bite Relief Patch
February 14, 2022
NEXGEL Announces the Launch of MEDAGEL ClearComfort Hydrogel Patch
January 11, 2022
NexGel, Inc. Announces Closing of $14.2 Million Initial Public Offering
December 26, 2021
NexGel, Inc. Announces Listing on Nasdaq and Pricing of $14.2 Million Initial Public Offering
December 20, 2021
Calls
The 5 newest of 17 calls. Every call is listed under its year.
- Nexgel (NASDAQ:NXGL) Q1 2026 Earnings Call
May 15, 2026
Transcript - Nexgel (NASDAQ:NXGL) Q4 2025 Earnings Call
Apr 21, 2026
Transcript - Nexgel (NASDAQ:NXGL) Q3 2025 Earnings Call
Nov 11, 2025
Transcript - Nexgel (NASDAQ:NXGL) Q2 2025 Earnings Call
Aug 12, 2025
Transcript - Nexgel (NASDAQ:NXGL) Q1 2025 Earnings Call
May 13, 2025
Transcript
Decks
The 5 newest of 12 decks. Every deck is listed under its year.
- Merger or Acquisition (September 2026)
Merger or acquisition · 16 slides · September 2026
- Investor Presentation (June 2026)
Investor deck · 16 slides · June 2026
- Q3 2025 Earnings Presentation
Earnings · 17 slides · Nov 12, 2025
- Q2 2025 Earnings Presentation
Earnings · 18 slides · Aug 12, 2025
- Investor Presentation (July 2025)
Investor deck · 18 slides · Jul 31, 2025